Renal · Glomerulonephritis
The facts most likely to be tested
Goodpasture syndrome is a Type II hypersensitivity reaction caused by anti-glomerular basement membrane (anti-GBM) antibodies directed against the alpha-3 chain of type IV collagen.
The classic clinical presentation is pulmonary-renal syndrome, characterized by the triad of hemoptysis, dyspnea, and rapidly progressive glomerulonephritis (RPGN).
Renal biopsy via immunofluorescence reveals pathognomonic linear IgG deposits along the glomerular basement membrane.
Light microscopy of the kidney typically demonstrates crescent formation in the glomeruli, which is the hallmark of crescentic glomerulonephritis.
The most accurate diagnostic test is the detection of circulating anti-GBM antibodies in the serum via ELISA.
Initial management requires urgent plasmapheresis to remove circulating pathogenic antibodies, combined with corticosteroids and cyclophosphamide to suppress further antibody production.
Goodpasture syndrome must be distinguished from Granulomatosis with polyangiitis (GPA), which typically presents with c-ANCA positivity and upper respiratory tract involvement (e.g., sinusitis, nasal septal perforation).
Vignette unlocked
A 28-year-old male presents to the emergency department with a two-week history of progressive dyspnea, productive cough with hemoptysis, and dark-colored urine. Physical examination reveals bilateral crackles on lung auscultation and pitting edema in the lower extremities. Laboratory studies show a serum creatinine of 4.2 mg/dL, hematuria, and dysmorphic red blood cells on urinalysis. A chest X-ray demonstrates bilateral alveolar opacities consistent with pulmonary hemorrhage.
What is the most likely finding on renal biopsy immunofluorescence?
Linear IgG deposits along the glomerular basement membrane
The patient's presentation of pulmonary-renal syndrome is classic for Goodpasture syndrome, which is pathognomonically diagnosed by linear IgG deposition on immunofluorescence.
Full handout
High yield triage
Etiology / Epidemiology
Autoimmune disorder targeting anti-GBM antibodies against type IV collagen. Bimodal distribution in young males and older adults.
Clinical Manifestations
Classic pulmonary-renal syndrome: hemoptysis and rapidly progressive glomerulonephritis (RPGN).
Diagnosis
Gold standard is renal biopsy showing linear IgG deposits. Serum anti-GBM antibody titers are highly specific.
Treatment
Immediate plasmapheresis to remove antibodies, plus cyclophosphamide and corticosteroids.
Prognosis
High risk of end-stage renal disease; early intervention is critical to prevent permanent renal failure.
Full handout
Epidemiology & Etiology
Primarily affects young males (20-30) and older adults (60-70). Triggered by environmental factors like smoking or hydrocarbon exposure in genetically susceptible individuals. It is a rare form of anti-glomerular basement membrane disease.
Pertinent Anatomy
Targets the type IV collagen in the glomerular basement membrane and the alveolar basement membrane. This dual-organ involvement explains the simultaneous presentation of lung and kidney failure.
Pathophysiology
Circulating anti-GBM antibodies bind to the non-collagenous domain of the alpha-3 chain of type IV collagen. This triggers a Type II hypersensitivity reaction, leading to complement activation and inflammatory destruction of the basement membrane. In the kidneys, this manifests as crescentic glomerulonephritis.
Clinical Manifestations
Patients present with pulmonary-renal syndrome characterized by hemoptysis, dyspnea, and cough. Renal involvement presents as hematuria, proteinuria, and rapidly progressive renal failure. Respiratory failure is a life-threatening complication requiring immediate stabilization.
Diagnosis
The renal biopsy is the gold standard, revealing linear IgG deposits along the glomerular basement membrane. Serum testing for anti-GBM antibodies via ELISA is highly sensitive and specific. Urinalysis typically shows dysmorphic RBCs and RBC casts.
Treatment
Urgent plasmapheresis is the cornerstone of therapy to rapidly clear circulating antibodies. Immunosuppression with cyclophosphamide and high-dose corticosteroids is required to halt further antibody production. Avoid nephrotoxic agents during the acute phase to preserve remaining renal function.
Prognosis
Prognosis is poor if the patient is dialysis-dependent at presentation. Key complications include permanent end-stage renal disease and pulmonary hemorrhage. Long-term monitoring of creatinine and antibody titers is mandatory.
Differential Diagnosis
Granulomatosis with polyangiitis: c-ANCA positive, upper airway involvement
Microscopic polyangiitis: p-ANCA positive, no immune deposits
Systemic Lupus Erythematosus: ANA positive, multisystem involvement
IgA Nephropathy: IgA deposits on biopsy, usually no pulmonary involvement
Post-streptococcal glomerulonephritis: low C3 levels, history of pharyngitis